Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
EWS/FLI fusion protein | 15 | 0 | 0 | 15 |
Apoptosis regulator Bcl-2 | 0 | 5 | 5 | 10 |
Spike glycoprotein | 5 | 0 | 0 | 5 |
Bcl-2-like protein 1 | 0 | 4 | 2 | 6 |
Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 5 | 0 | 5 |
Aspartyl/asparaginyl beta-hydroxylase | 0 | 2 | 0 | 2 |
Bcl-2-related protein A1 | 0 | 2 | 1 | 3 |
Bcl-2-like protein 2 | 0 | 3 | 0 | 3 |
Bcl2-associated agonist of cell death | 0 | 2 | 0 | 2 |
Chain A, Apoptosis regulator Bcl-X | 0 | 1 | 0 | 1 |
PPM1D protein | 4 | 0 | 0 | 4 |
Bcl-2-like protein 11 | 0 | 1 | 0 | 1 |
Interferon beta | 5 | 0 | 0 | 5 |
Beta-casein | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 0 | 2 |
BH3-interacting domain death agonist | 0 | 2 | 0 | 2 |
Induced myeloid leukemia cell differentiation protein Mcl-1 homolog | 0 | 0 | 1 | 1 |
Apoptosis regulator BAX | 0 | 1 | 0 | 1 |
Bcl-2 homologous antagonist/killer | 0 | 2 | 1 | 3 |
Bcl-2-binding component 3, isoforms 1/2 | 0 | 1 | 0 | 1 |
Bcl-2-like protein 10 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 4 | 0 | 4 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
RAR-related orphan receptor gamma | 8 | 0 | 0 | 8 |
TDP1 protein | 13 | 0 | 0 | 13 |
AR protein | 12 | 0 | 0 | 12 |
nuclear receptor subfamily 1, group I, member 3 | 7 | 0 | 0 | 7 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 5 | 0 | 0 | 5 |
glucocorticoid receptor [Homo sapiens] | 8 | 0 | 0 | 8 |
estrogen-related nuclear receptor alpha | 12 | 0 | 0 | 12 |
pregnane X nuclear receptor | 7 | 0 | 0 | 7 |
estrogen nuclear receptor alpha | 13 | 0 | 0 | 13 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 7 | 0 | 0 | 7 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
Bile salt export pump | 0 | 13 | 0 | 13 |
Cyclin-dependent kinase 1 | 0 | 1 | 2 | 3 |
Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 5 | 2 | 1 | 8 |
Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 3 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 5 | 0 | 0 | 5 |
Ataxin-2 | 5 | 0 | 0 | 5 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 5 |
Alanine racemase, biosynthetic | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 5 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
interleukin 8 | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
progesterone receptor | 5 | 0 | 0 | 5 |
IDH1 | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 7 | 0 | 0 | 7 |
Bloom syndrome protein isoform 1 | 6 | 0 | 0 | 6 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 8 | 0 | 0 | 8 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
geminin | 9 | 0 | 0 | 9 |
survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 9 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Cellular tumor antigen p53 | 11 | 2 | 0 | 13 |
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 0 | 1 | 1 |
Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 2 | 1 | 4 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 9 | 0 | 9 |
Shiga toxin subunit A | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Chain H, Proteasome component PUP1 | 0 | 1 | 0 | 1 |
Chain I, Proteasome component PUP3 | 0 | 1 | 0 | 1 |
Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-11 | 0 | 1 | 0 | 1 |
Fumarate hydratase | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
polyprotein | 3 | 0 | 0 | 3 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
caspase-3 | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Histone H2A.x | 2 | 0 | 0 | 2 |
Caspase-7 | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
26S proteasome non-ATPase regulatory subunit 11 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 12 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 14 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-7 | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
Prothrombin | 0 | 1 | 1 | 2 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
Cathepsin B | 0 | 1 | 0 | 1 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Cathepsin G | 0 | 2 | 0 | 2 |
Lysosomal protective protein | 0 | 1 | 0 | 1 |
Chymotrypsinogen B | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 6A | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-1 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
Chymase | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-1 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
26S proteasome regulatory subunit 7 | 0 | 1 | 0 | 1 |
Lon protease homolog, mitochondrial | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-10 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
26S proteasome regulatory subunit 6B | 0 | 1 | 2 | 3 |
26S proteasome non-ATPase regulatory subunit 8 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-3 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 1 | 0 | 2 |
26S proteasome non-ATPase regulatory subunit 7 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 4 | 0 | 1 | 0 | 1 |
26S proteasome complex subunit SEM1 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 4 | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 8 | 0 | 1 | 0 | 1 |
26S proteasome regulatory subunit 10B | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
Transcription factor p65 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 2 | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 2 | 0 | 2 |
26S proteasome non-ATPase regulatory subunit 6 | 0 | 1 | 0 | 1 |
Proteasomal ubiquitin receptor ADRM1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 3 |
ATP-dependent Clp protease proteolytic subunit | 0 | 1 | 1 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Proteasome subunit alpha-type 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-7 | 0 | 1 | 0 | 1 |
26S proteasome non-ATPase regulatory subunit 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
26S proteasome non-ATPase regulatory subunit 13 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
Luciferase | 3 | 0 | 0 | 3 |
thioredoxin reductase | 8 | 0 | 0 | 8 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
GLS protein | 4 | 0 | 0 | 4 |
GLI family zinc finger 3 | 6 | 0 | 0 | 6 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
Thrombopoietin | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
Cytochrome P450 2D6 | 0 | 5 | 1 | 6 |
Nuclear receptor ROR-gamma | 3 | 1 | 1 | 5 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
67.9K protein | 4 | 0 | 0 | 4 |
exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
Smad3 | 3 | 0 | 0 | 3 |
corticotropin-releasing hormone receptor 2 | 0 | 1 | 1 | 2 |
corticotropin releasing factor-binding protein | 0 | 1 | 1 | 2 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 2 | 2 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 1 | 0 | 3 |
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 6 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
Integrin beta-3 | 0 | 0 | 1 | 1 |
Integrin alpha-IIb | 0 | 0 | 1 | 1 |
ATP-citrate synthase | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 2 | 1 | 3 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
Excitatory amino acid transporter 1 | 0 | 2 | 0 | 3 |
Excitatory amino acid transporter 2 | 0 | 2 | 0 | 3 |
Excitatory amino acid transporter 3 | 0 | 2 | 0 | 3 |
Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 4 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 4 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 4 |
Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 2 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 4 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 4 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 4 |
Bone morphogenetic protein receptor type-1B | 0 | 0 | 2 | 2 |
Membrane-associated progesterone receptor component 1 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 0 | 1 | 1 | 2 |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PLK4 | 0 | 0 | 2 | 2 |
ATP-dependent RNA helicase DDX3X | 0 | 0 | 2 | 2 |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | 0 | 1 | 0 | 1 |
Pyridoxal kinase | 0 | 0 | 2 | 2 |
Citron Rho-interacting kinase | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase Chk1 | 0 | 0 | 2 | 2 |
Aurora kinase A | 0 | 0 | 2 | 2 |
Cyclin-G-associated kinase | 0 | 0 | 2 | 2 |
Ephrin type-B receptor 6 | 0 | 0 | 2 | 2 |
Peroxisomal acyl-coenzyme A oxidase 3 | 0 | 0 | 2 | 2 |
Receptor-interacting serine/threonine-protein kinase 2 | 0 | 0 | 2 | 2 |
Mitotic checkpoint serine/threonine-protein kinase BUB1 | 0 | 0 | 2 | 2 |
Dynamin-like 120 kDa protein, mitochondrial | 0 | 0 | 2 | 2 |
Eukaryotic translation initiation factor 5B | 0 | 0 | 1 | 1 |
Rho-associated protein kinase 2 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase ULK1 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase/endoribonuclease IRE1 | 0 | 0 | 2 | 2 |
Ribosomal protein S6 kinase alpha-5 | 0 | 0 | 2 | 2 |
U5 small nuclear ribonucleoprotein 200 kDa helicase | 0 | 0 | 2 | 2 |
Ribosomal protein S6 kinase alpha-4 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase 16 | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase-like 5 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 10 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase D3 | 0 | 0 | 2 | 2 |
Structural maintenance of chromosomes protein 2 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase 6 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase kinase 4 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase LATS1 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase PAK 4 | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 2 | 3 |
Epidermal growth factor receptor | 0 | 3 | 3 | 6 |
High affinity nerve growth factor receptor | 0 | 0 | 2 | 2 |
Guanine nucleotide-binding protein G(i) subunit alpha-2 | 0 | 0 | 2 | 2 |
ADP/ATP translocase 2 | 0 | 0 | 2 | 2 |
Cytochrome P450 1A2 | 0 | 3 | 1 | 4 |
Protein kinase C beta type | 0 | 0 | 2 | 2 |
Insulin receptor | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase Lck | 0 | 2 | 2 | 4 |
Tyrosine-protein kinase Fyn | 0 | 2 | 2 | 4 |
Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase Fes/Fps | 0 | 0 | 2 | 2 |
Adenine phosphoribosyltransferase | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase Yes | 0 | 1 | 2 | 3 |
Tyrosine-protein kinase Lyn | 0 | 1 | 2 | 3 |
Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 2 | 3 |
Insulin-like growth factor 1 receptor | 0 | 0 | 2 | 2 |
Signal recognition particle receptor subunit alpha | 0 | 0 | 2 | 2 |
Cytochrome c1, heme protein, mitochondrial | 0 | 0 | 2 | 2 |
Hepatocyte growth factor receptor | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase HCK | 0 | 1 | 2 | 3 |
Platelet-derived growth factor receptor beta | 0 | 1 | 2 | 3 |
Tyrosine-protein kinase Fgr | 0 | 1 | 1 | 2 |
Serine/threonine-protein kinase A-Raf | 0 | 0 | 2 | 2 |
Glycogen phosphorylase, brain form | 0 | 0 | 2 | 2 |
Breakpoint cluster region protein | 0 | 0 | 2 | 3 |
Serine/threonine-protein kinase pim-1 | 0 | 0 | 2 | 2 |
Fibroblast growth factor receptor 1 | 0 | 0 | 2 | 2 |
DNA topoisomerase 2-alpha | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 4 | 0 | 0 | 2 | 2 |
ADP/ATP translocase 3 | 0 | 0 | 2 | 2 |
Inosine-5'-monophosphate dehydrogenase 2 | 0 | 0 | 2 | 2 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 2 | 3 |
cAMP-dependent protein kinase type II-alpha regulatory subunit | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase B-raf | 0 | 0 | 2 | 2 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 0 | 0 | 2 | 2 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 2 | 4 |
Tyrosine-protein kinase Fer | 0 | 0 | 2 | 2 |
Protein kinase C alpha type | 0 | 0 | 2 | 2 |
cAMP-dependent protein kinase catalytic subunit alpha | 0 | 0 | 2 | 2 |
General transcription and DNA repair factor IIH helicase subunit XPD | 0 | 0 | 2 | 2 |
Casein kinase II subunit alpha' | 0 | 0 | 2 | 2 |
Ras-related protein Rab-6A | 0 | 0 | 2 | 2 |
Ephrin type-A receptor 1 | 0 | 0 | 2 | 2 |
Multifunctional protein ADE2 | 0 | 0 | 2 | 2 |
cAMP-dependent protein kinase catalytic subunit gamma | 0 | 0 | 2 | 2 |
cAMP-dependent protein kinase catalytic subunit beta | 0 | 0 | 2 | 2 |
Ferrochelatase, mitochondrial | 0 | 0 | 2 | 2 |
Ribosomal protein S6 kinase beta-1 | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase JAK1 | 0 | 2 | 2 | 4 |
Cyclin-dependent kinase 2 | 0 | 1 | 2 | 3 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 2 | 2 |
Probable ATP-dependent RNA helicase DDX6 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 3 | 0 | 0 | 2 | 2 |
MAP/microtubule affinity-regulating kinase 3 | 0 | 0 | 2 | 2 |
Deoxycytidine kinase | 0 | 0 | 2 | 2 |
Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 1 | 0 | 1 | 2 | 3 |
Ephrin type-A receptor 2 | 0 | 1 | 2 | 3 |
Ephrin type-B receptor 2 | 0 | 0 | 2 | 2 |
Non-receptor tyrosine-protein kinase TYK2 | 0 | 0 | 2 | 2 |
Phosphatidylethanolamine-binding protein 1 | 0 | 0 | 2 | 2 |
Wee1-like protein kinase | 0 | 0 | 2 | 2 |
Heme oxygenase 2 | 0 | 0 | 2 | 2 |
S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 2 | 2 |
DnaJ homolog subfamily A member 1 | 0 | 0 | 2 | 2 |
RAC-alpha serine/threonine-protein kinase | 0 | 0 | 2 | 2 |
RAC-beta serine/threonine-protein kinase | 0 | 0 | 2 | 2 |
Cytochrome P450 2C19 | 0 | 3 | 1 | 5 |
DNA replication licensing factor MCM4 | 0 | 0 | 2 | 2 |
Dual specificity mitogen-activated protein kinase kinase 2 | 0 | 1 | 2 | 3 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 2 | 2 | 4 |
Bone morphogenetic protein receptor type-1A | 0 | 0 | 2 | 2 |
Activin receptor type-1B | 0 | 0 | 2 | 2 |
TGF-beta receptor type-1 | 0 | 0 | 2 | 2 |
TGF-beta receptor type-2 | 0 | 0 | 2 | 2 |
Electron transfer flavoprotein subunit beta | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase CSK | 0 | 1 | 2 | 3 |
Glycine--tRNA ligase | 0 | 0 | 2 | 2 |
Protein kinase C iota type | 0 | 0 | 2 | 2 |
Exosome RNA helicase MTR4 | 0 | 0 | 2 | 2 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Tec | 0 | 1 | 2 | 3 |
Tyrosine-protein kinase ABL2 | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase FRK | 0 | 1 | 2 | 3 |
G protein-coupled receptor kinase 6 | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase SYK | 0 | 1 | 2 | 3 |
Mitogen-activated protein kinase 8 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 9 | 0 | 0 | 2 | 2 |
Dual specificity mitogen-activated protein kinase kinase 4 | 0 | 0 | 1 | 1 |
Dual specificity mitogen-activated protein kinase kinase 3 | 0 | 0 | 2 | 2 |
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0 | 0 | 2 | 2 |
Casein kinase I isoform alpha | 0 | 0 | 1 | 1 |
Casein kinase I isoform delta | 0 | 0 | 2 | 2 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
MAP kinase-activated protein kinase 2 | 0 | 0 | 2 | 2 |
Elongation factor Tu, mitochondrial | 0 | 0 | 2 | 2 |
Cysteine--tRNA ligase, cytoplasmic | 0 | 0 | 1 | 1 |
Casein kinase I isoform epsilon | 0 | 0 | 2 | 2 |
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | 0 | 0 | 2 | 2 |
Dual specificity protein kinase CLK1 | 0 | 0 | 2 | 2 |
Dual specificity protein kinase CLK2 | 0 | 0 | 2 | 2 |
Glycogen synthase kinase-3 alpha | 0 | 0 | 2 | 2 |
Glycogen synthase kinase-3 beta | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 7 | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 9 | 0 | 0 | 2 | 2 |
Ras-related protein Rab-27A | 0 | 0 | 2 | 2 |
Interleukin-1 receptor-associated kinase 1 | 0 | 0 | 2 | 2 |
Ribosomal protein S6 kinase alpha-3 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase Nek2 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase Nek3 | 0 | 0 | 2 | 2 |
Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase PLK1 | 0 | 0 | 2 | 2 |
LIM domain kinase 1 | 0 | 0 | 2 | 2 |
LIM domain kinase 2 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 10 | 0 | 0 | 2 | 2 |
Tyrosine--tRNA ligase, cytoplasmic | 0 | 0 | 2 | 2 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 2 |
Ephrin type-B receptor 3 | 0 | 0 | 2 | 2 |
Ephrin type-A receptor 5 | 0 | 0 | 2 | 2 |
Ephrin type-B receptor 4 | 0 | 0 | 2 | 2 |
Ephrin type-A receptor 4 | 0 | 0 | 2 | 2 |
Adenylate kinase 2, mitochondrial | 0 | 0 | 2 | 2 |
Adenosine kinase | 0 | 0 | 2 | 2 |
Ras-related protein Rab-10 | 0 | 0 | 2 | 2 |
Actin-related protein 3 | 0 | 0 | 2 | 2 |
Actin-related protein 2 | 0 | 0 | 2 | 2 |
GTP-binding nuclear protein Ran | 0 | 0 | 2 | 2 |
Casein kinase I isoform gamma-2 | 0 | 0 | 2 | 2 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 3 | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 6 | 0 | 0 | 2 | 2 |
Cyclin-dependent-like kinase 5 | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 16 | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 17 | 0 | 0 | 2 | 2 |
ATP-dependent 6-phosphofructokinase, platelet type | 0 | 0 | 2 | 2 |
Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 0 | 2 | 2 |
DNA topoisomerase 2-beta | 0 | 0 | 2 | 2 |
Protein kinase C theta type | 0 | 0 | 2 | 2 |
Activin receptor type-1 | 0 | 0 | 2 | 2 |
Macrophage-stimulating protein receptor | 0 | 0 | 2 | 2 |
Focal adhesion kinase 1 | 0 | 0 | 2 | 2 |
Protein kinase C delta type | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase BTK | 0 | 2 | 3 | 5 |
Activated CDC42 kinase 1 | 0 | 0 | 2 | 2 |
Epithelial discoidin domain-containing receptor 1 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase kinase 2 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase 4 | 0 | 0 | 2 | 2 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 2 | 2 |
Dual specificity mitogen-activated protein kinase kinase 5 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 7 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase PAK 2 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase 3 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase 1 | 0 | 0 | 2 | 2 |
Integrin-linked protein kinase | 0 | 0 | 2 | 2 |
Rho-associated protein kinase 1 | 0 | 0 | 2 | 2 |
Non-receptor tyrosine-protein kinase TNK1 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase ATR | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma | 0 | 0 | 2 | 2 |
Calcium/calmodulin-dependent protein kinase type II subunit delta | 0 | 0 | 2 | 2 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 2 | 2 |
Activin receptor type-2B | 0 | 0 | 2 | 2 |
Bone morphogenetic protein receptor type-2 | 0 | 0 | 2 | 2 |
Protein-tyrosine kinase 6 | 0 | 1 | 2 | 3 |
cGMP-dependent protein kinase 1 | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 13 | 0 | 0 | 2 | 2 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 0 | 0 | 2 | 2 |
Protein-tyrosine kinase 2-beta | 0 | 0 | 2 | 2 |
Maternal embryonic leucine zipper kinase | 0 | 0 | 2 | 2 |
Structural maintenance of chromosomes protein 1A | 0 | 0 | 2 | 2 |
Chromodomain-helicase-DNA-binding protein 4 | 0 | 0 | 2 | 2 |
Peroxisomal acyl-coenzyme A oxidase 1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 38 | 0 | 0 | 2 | 2 |
Ephrin type-A receptor 7 | 0 | 0 | 2 | 2 |
Delta(24)-sterol reductase | 0 | 0 | 2 | 2 |
Ribosomal protein S6 kinase alpha-1 | 0 | 1 | 2 | 3 |
Dual specificity testis-specific protein kinase 1 | 0 | 0 | 1 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 11 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase STK11 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase N1 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase N2 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 14 | 0 | 0 | 2 | 2 |
Calcium/calmodulin-dependent protein kinase type IV | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase 11 | 0 | 0 | 2 | 2 |
MAP kinase-activated protein kinase 3 | 0 | 0 | 2 | 2 |
Discoidin domain-containing receptor 2 | 0 | 0 | 2 | 2 |
AP2-associated protein kinase 1 | 0 | 0 | 2 | 2 |
Myosin light chain kinase 3 | 0 | 0 | 2 | 2 |
Uncharacterized aarF domain-containing protein kinase 5 | 0 | 0 | 1 | 1 |
Putative heat shock protein HSP 90-beta 2 | 0 | 0 | 2 | 2 |
Rab-like protein 3 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase MRCK alpha | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase MRCK gamma | 0 | 0 | 2 | 2 |
Acyl-CoA dehydrogenase family member 10 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase N3 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase ULK3 | 0 | 0 | 2 | 2 |
Uncharacterized protein FLJ45252 | 0 | 0 | 2 | 2 |
Acyl-CoA dehydrogenase family member 11 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase/endoribonuclease IRE2 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase MARK2 | 0 | 0 | 2 | 2 |
ATP-dependent RNA helicase DHX30 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase TAO1 | 0 | 0 | 2 | 2 |
STE20-related kinase adapter protein alpha | 0 | 0 | 2 | 2 |
AarF domain-containing protein kinase 1 | 0 | 0 | 2 | 2 |
ATP-dependent RNA helicase DDX42 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase kinase 3 | 0 | 0 | 2 | 2 |
MAP kinase-activated protein kinase 5 | 0 | 0 | 2 | 2 |
Misshapen-like kinase 1 | 0 | 0 | 2 | 2 |
Phosphatidylinositol 3-kinase catalytic subunit type 3 | 0 | 1 | 0 | 1 |
Atypical kinase COQ8A, mitochondrial | 0 | 0 | 2 | 2 |
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 15 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase Nek9 | 0 | 0 | 2 | 2 |
ATP-dependent RNA helicase DDX1 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase kinase 1 | 0 | 0 | 2 | 2 |
Aurora kinase B | 0 | 0 | 2 | 2 |
MAP/microtubule affinity-regulating kinase 4 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase Nek1 | 0 | 0 | 2 | 2 |
PAS domain-containing serine/threonine-protein kinase | 0 | 0 | 2 | 2 |
Calcium/calmodulin-dependent protein kinase kinase 2 | 0 | 0 | 2 | 2 |
EKC/KEOPS complex subunit TP53RK | 0 | 0 | 2 | 2 |
Dual specificity testis-specific protein kinase 2 | 0 | 0 | 1 | 1 |
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase 5 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase 3 | 0 | 0 | 2 | 2 |
Eukaryotic translation initiation factor 2-alpha kinase 1 | 0 | 0 | 2 | 2 |
Nucleolar GTP-binding protein 1 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase D2 | 0 | 0 | 2 | 2 |
NUAK family SNF1-like kinase 2 | 0 | 0 | 2 | 2 |
RNA cytidine acetyltransferase | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase SIK2 | 0 | 0 | 2 | 2 |
STE20-like serine/threonine-protein kinase | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase TAO3 | 0 | 0 | 2 | 2 |
dCTP pyrophosphatase 1 | 0 | 0 | 2 | 2 |
Dual specificity protein kinase CLK4 | 0 | 0 | 2 | 2 |
Casein kinase I isoform gamma-1 | 0 | 0 | 2 | 2 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 6 | 0 | 0 | 2 | 2 |
Phenylalanine--tRNA ligase beta subunit | 0 | 0 | 2 | 2 |
BMP-2-inducible protein kinase | 0 | 0 | 2 | 2 |
Midasin | 0 | 0 | 2 | 2 |
Interleukin-1 receptor-associated kinase 4 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase 20 | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 12 | 0 | 0 | 2 | 2 |
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase 26 | 0 | 0 | 2 | 2 |
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase NLK | 0 | 0 | 2 | 2 |
Phosphatidylinositol 4-kinase beta | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase TBK1 | 0 | 0 | 2 | 2 |
Septin-9 | 0 | 0 | 2 | 2 |
Ribosomal protein S6 kinase alpha-6 | 0 | 0 | 2 | 2 |
TRAF2 and NCK-interacting protein kinase | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase TAO2 | 0 | 0 | 2 | 2 |
Long-chain-fatty-acid--CoA ligase 5 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase ICK | 0 | 0 | 2 | 2 |
RAC-gamma serine/threonine-protein kinase | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase 38-like | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase SIK3 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase 2 | 0 | 0 | 2 | 2 |
Thyroid hormone receptor-associated protein 3 | 0 | 0 | 2 | 2 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase kinase 5 | 0 | 0 | 2 | 2 |
Receptor-interacting serine/threonine-protein kinase 3 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase MRCK beta | 0 | 0 | 2 | 2 |
Interleukin-1 receptor-associated kinase 3 | 0 | 0 | 2 | 2 |
Serine/threonine-protein kinase 24 | 0 | 0 | 2 | 2 |
Casein kinase I isoform gamma-3 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase kinase kinase 4 | 0 | 0 | 2 | 2 |
Cereblon isoform 4 | 0 | 3 | 0 | 3 |
Bromodomain-containing protein 4 | 0 | 1 | 0 | 1 |
DNA-binding protein Ikaros | 0 | 0 | 1 | 4 |
DNA damage-binding protein 1 | 0 | 2 | 1 | 3 |
Protein cereblon | 0 | 4 | 2 | 9 |
Zinc finger protein Aiolos | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
arylsulfatase A | 2 | 0 | 0 | 2 |
pyruvate kinase | 1 | 0 | 0 | 1 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
SLC16A10 protein | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
ClpP | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 4 | 0 | 4 |
Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
Protein Mdm4 | 0 | 2 | 0 | 2 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 0 | 1 | 1 |
Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
E3 ubiquitin-protein ligase Mdm2 | 1 | 2 | 1 | 4 |
Peptidyl-prolyl cis-trans isomerase D | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
Cell division cycle 7-related protein kinase | 0 | 0 | 1 | 1 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Putative nucleoside diphosphate kinase | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase JAK2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 1 | 2 |
Macrophage colony-stimulating factor 1 receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 2 | 1 | 4 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 2 | 1 | 4 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-3 | 0 | 1 | 0 | 1 |
Nucleoside diphosphate kinase B | 0 | 0 | 1 | 1 |
G1/S-specific cyclin-E1 | 0 | 1 | 0 | 1 |
Dual specificity protein kinase TTK | 0 | 0 | 1 | 1 |
Myosin-10 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase TXK | 0 | 1 | 1 | 2 |
Choline-phosphate cytidylyltransferase A | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Blk | 0 | 1 | 1 | 2 |
Cytoplasmic tyrosine-protein kinase BMX | 0 | 2 | 1 | 3 |
cAMP-dependent protein kinase catalytic subunit PRKX | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase JAK3 | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase ITK/TSK | 0 | 1 | 1 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 4 |
Tyrosine-protein kinase Mer | 0 | 0 | 1 | 1 |
Receptor tyrosine-protein kinase erbB-4 | 0 | 1 | 1 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Myosin-14 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Nek7 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 3 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type 1G | 0 | 0 | 1 | 1 |
Peroxiredoxin-like 2A | 0 | 1 | 0 | 1 |
Platelet glycoprotein VI | 0 | 1 | 0 | 1 |
Obg-like ATPase 1 | 0 | 0 | 1 | 1 |
Adenosine deaminase | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 1 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Albumin | 0 | 0 | 2 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
D | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Alpha-synuclein | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Adenosylhomocysteinase | 0 | 1 | 0 | 1 |
RNA-directed RNA polymerase | 0 | 1 | 1 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |